FDA
-
-
-
-
-
-
-
Vaxart secures $25 million equity financing deal with Lincoln Park
-
-
-
-
-
-
-
Vaxart reports improved immune response in norovirus vaccine trial
-
-
-
-
-
-
-
Vaxart Receives BARDA Approval to Initiate Dosing in 10,000-Participant Portion of Phase 2b COVID-19 Trial
-
-
-
-
-
-
-
Vaxart Provides Business Update and Reports Full Year 2024 Financial Results
-
-
-
-
-
-
-
Vaxart Highlights Progress of COVID-19, Norovirus and Influenza Programs
-
-
-
-
-
-
-
Vaxart Provides Business Update and Reports Second Quarter 2024 Financial Results
-
-
-
-
-
-
-
Vaxart Announces Positive Results for Its Bivalent Norovirus Vaccine Candidate in Lactating Mothers
-
322,084 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

